Molecular cancer therapeutics, 1535-7163

Journal

View graph of relations

Related Publications
  1. Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

    de Boer, H. R., Joosten, E., Fusetti, F., Fehrmann, R. SN., de Vries, E. G. E. & van Vugt, M. ATM., Dec-2015, In : Molecular cancer therapeutics. 14, 12, B19.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Preclinical Efficacy of an Antibody-Drug Conjugate Targeting Mesothelin Correlates with Quantitative Zr-89-ImmunoPET

    Terwisscha Van Scheltinga, A., Ogasawara, A., Pacheco, G., Vanderbilt, A. N., Tinianow, J. N., Gupta, N., Li, D., Firestein, R., Marik, J., Scales, S. J. & Williams, S-P., Jan-2017, In : Molecular cancer therapeutics. 16, 1, p. 134-142 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

    Weekes, C. D., Lamberts, L. E., Borad, M. J., Voortman, J., McWilliams, R. R., Diamond, J. R., de Vries, E. G. E., Verheul, H. M., Lieu, C. H., Kim, G. P., Wang, Y., Scales, S. J., Samineni, D., Brunstein, F., Choi, Y., Maslyar, D. J. & Colon-Otero, G., Mar-2016, In : Molecular cancer therapeutics. 15, 3, p. 439-447 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Therapeutic potential of the poly(ADP-ribose) polymerase inhibitor rucaparib for the treatment of sporadic human ovarian cancer

    Ihnen, M., zu Eulenburg, C., Kolarova, T., Qi, J. W., Manivong, K., Chalukya, M., Dering, J., Anderson, L., Ginther, C., Meuter, A., Winterhoff, B., Jones, S., Velculescu, V. E., Venkatesan, N., Rong, H-M., Dandekar, S., Udar, N., Jaenicke, F., Los, G., Slamon, D. J. & Konecny, G. E., Jun-2013, In : Molecular cancer therapeutics. 12, 6, p. 1002-1015 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCl-H460

    Voortman, J., Checinska, A., Giaccone, G., Rodriguez, J. A. & Kruyt, F. A. E., Mar-2007, In : Molecular cancer therapeutics. 6, 3, p. 1046-1053 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (12) »

ID: 4052113